Apoptosis in cancer: from pathogenesis to treatment

被引:0
作者
Rebecca SY Wong
机构
[1] International Medical University,Division of Human Biology, School of Medical and Health Sciences
来源
Journal of Experimental & Clinical Cancer Research | / 30卷
关键词
Apoptosis; defective apoptotic pathways; carcinogenesis; treatment target;
D O I
暂无
中图分类号
学科分类号
摘要
Apoptosis is an ordered and orchestrated cellular process that occurs in physiological and pathological conditions. It is also one of the most studied topics among cell biologists. An understanding of the underlying mechanism of apoptosis is important as it plays a pivotal role in the pathogenesis of many diseases. In some, the problem is due to too much apoptosis, such as in the case of degenerative diseases while in others, too little apoptosis is the culprit. Cancer is one of the scenarios where too little apoptosis occurs, resulting in malignant cells that will not die. The mechanism of apoptosis is complex and involves many pathways. Defects can occur at any point along these pathways, leading to malignant transformation of the affected cells, tumour metastasis and resistance to anticancer drugs. Despite being the cause of problem, apoptosis plays an important role in the treatment of cancer as it is a popular target of many treatment strategies. The abundance of literature suggests that targeting apoptosis in cancer is feasible. However, many troubling questions arise with the use of new drugs or treatment strategies that are designed to enhance apoptosis and critical tests must be passed before they can be used safely in human subjects.
引用
收藏
相关论文
共 588 条
[1]  
Bauer JH(2006)New tricks of an old molecule: lifespan regulation by p53 Aging Cell 5 437-440
[2]  
Hefand SL(2002)The p53 pathway in breast cancer Breast Cancer Res 4 70-76
[3]  
Gasco M(1990)p53 mutations in colorectal cancers Proc Natl Acad Sci USA 87 7555-7559
[4]  
Shami S(2010)Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer PNAS 107 246-251
[5]  
Crook T(2008)Phase I study of a novel pro-apoptotic drug R-etodolac in patients with B-cell chronic lymphocytic leukaemia Invest New Drugs 26 139-149
[6]  
Rodrigues NR(2011)The anti-CD20 mAb LFB-R603 interrupts the dysregulated NF-κB/Snail/RKIP/PTEN resistance loop in B-NHL cells: role in sensitization to TRAIL apoptosis Int J Oncol 38 1683-1694
[7]  
Rowan A(1972)Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics Br J Cancer 26 239-257
[8]  
Smith ME(2000)The morphology of apoptosis Cell Tissue Res 301 5-17
[9]  
Kerr IB(2000)Morphologic and biochemical hallmarks of apoptosis Cardiovascular Res 45 528-537
[10]  
Bodmer WF(2004)Morphological features of cell death News Physiol Sci 19 124-128